Is Novartis' LCZ696 the next gold standard of heart failure drugs?
Following the impressive results of the PARADIGM-HF study, some already speculate on the possibility of Novartis' LCZ696 becoming the next gold standard of treatment for heart failure. (Photo : Helen Penjam). Novartis may soon offer a new cardiac ...
A New Novartis Heart Failure Drug Might Be A Blockbuster
Novartis' New Heart Failure Drug Could Be Groundbreaking, Though 'LCZ696 ...
Heart Failure Trial Shut Down After Primary Endpoint Met